Vident Advisory, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1744347 Alpharetta, GA

Position in VRTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$7,172,769

+$968,540 QoQ

Shares Held

16,063

+17.4% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 69.46398555686983.ToString("F0")% Shared 0.ToString("F0")% None 30.536014443130178.ToString("F0")%

Healthcare · as of Mar 31, 2026

Vident Advisory, LLC holds $44,934,093 across 44 Biotechnology names. VRTX ranks #1 (16.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	16,063	$7,172,769
2	EXEL	Exelixis, Inc.	148,830	$6,383,317
3	JAZZ	Jazz Pharmaceuticals plc	23,032	$4,354,199
4	REGN	Regeneron Pharmaceuticals, Inc.	3,449	$2,664,834
5	ALNY	Alnylam Pharmaceuticals, Inc.	6,457	$2,136,426
6	INSM	INSMED Inc	9,808	$1,603,803
7	GMAB	Genmab A/S	48,379	$1,298,008
8	CYTK	Cytokinetics Inc	17,069	$1,125,017

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,172,769	16,063	+17.4%	Shares	Defined	2026-05-15
2025-12-31	$6,204,229	13,685	+3.5%	Shares	Defined	2026-02-18
2025-09-30	$5,178,262	13,222	-28.5%	Shares	Sole	2025-11-14
2025-06-30	$8,236,199	18,500	+15.1%	Shares	Sole	2025-08-14
2025-03-31	$7,794,935	16,078	-18.9%	Shares	Defined	2025-05-15
2024-12-31	$7,987,151	19,834	+137.3%	Shares	Defined	2025-02-14
2024-09-30	$3,887,137	8,358	+4.5%	Shares	Sole	2024-11-14
2024-06-30	$3,747,884	7,996	-84.5%	Shares	Defined	2024-08-14
2024-03-31	$21,538,800	51,527	+16.6%	Shares	Defined	2024-05-14
2023-12-31	$17,976,398	44,180	-9.0%	Shares	Sole	2024-02-14
2023-09-30	$16,891,817	48,576	—	Shares	Defined	2024-02-21
No filing history on record for this holder in this stock.